Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Kinross Gold | 5.66% | $2.92M | $37.23B | 195.98% | 81 Outperform | |
| BAE Systems | 4.31% | $2.22M | £59.91B | 87.32% | 61 Neutral | |
| Novartis AG | 4.20% | $2.16M | CHF217.04B | 25.19% | 80 Outperform | |
| Rio Tinto Limited | 4.04% | $2.08M | AU$204.34B | 36.60% | 78 Outperform | |
| Nutrien | 3.76% | $1.94M | $28.85B | 23.38% | 75 Outperform | |
| Sony | 3.43% | $1.77M | ¥23.68T | 19.66% | 73 Outperform | |
| Sumitomo Mitsui Financial Group | 3.19% | $1.64M | ¥20.21T | 42.45% | 77 Outperform | |
| Nordea Bank Abp | 3.12% | $1.61M | kr599.30B | 69.57% | ― | |
| NatWest Group | 3.07% | $1.58M | £51.34B | 71.63% | 75 Outperform | |
| AstraZeneca | 3.06% | $1.58M | £220.41B | 29.45% | 80 Outperform |